A. Murtaja Et Al. , "The ribosome inhibiting protein riproximin shows antineoplastic activity in experimental pancreatic cancer liver metastasis," ONCOLOGY LETTERS , vol.15, no.2, pp.1441-1448, 2018
Murtaja, A. Et Al. 2018. The ribosome inhibiting protein riproximin shows antineoplastic activity in experimental pancreatic cancer liver metastasis. ONCOLOGY LETTERS , vol.15, no.2 , 1441-1448.
Murtaja, A., Eyol, E., Jiang Xiaoqi, J. X., Berger, M. R., & Adwan, H., (2018). The ribosome inhibiting protein riproximin shows antineoplastic activity in experimental pancreatic cancer liver metastasis. ONCOLOGY LETTERS , vol.15, no.2, 1441-1448.
Murtaja, Ahmed Et Al. "The ribosome inhibiting protein riproximin shows antineoplastic activity in experimental pancreatic cancer liver metastasis," ONCOLOGY LETTERS , vol.15, no.2, 1441-1448, 2018
Murtaja, Ahmed Et Al. "The ribosome inhibiting protein riproximin shows antineoplastic activity in experimental pancreatic cancer liver metastasis." ONCOLOGY LETTERS , vol.15, no.2, pp.1441-1448, 2018
Murtaja, A. Et Al. (2018) . "The ribosome inhibiting protein riproximin shows antineoplastic activity in experimental pancreatic cancer liver metastasis." ONCOLOGY LETTERS , vol.15, no.2, pp.1441-1448.
@article{article, author={Ahmed Murtaja Et Al. }, title={The ribosome inhibiting protein riproximin shows antineoplastic activity in experimental pancreatic cancer liver metastasis}, journal={ONCOLOGY LETTERS}, year=2018, pages={1441-1448} }